Related references
Note: Only part of the references are listed.Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
Patrick Jault et al.
LANCET INFECTIOUS DISEASES (2019)
Phage Therapy Faces Evolutionary Challenges
Clara Torres-Barcelo
VIRUSES-BASEL (2018)
Phage Therapy for a MultidrugResistant Acinetobacter baumannii Craniectomy Site Infection
Stephanie LaVergne et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
A Wake-Up Call: We Need Phage Therapy Now
Karin Moelling et al.
VIRUSES-BASEL (2018)
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
Lucy L. Furfaro et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection
Robert T. Schooley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Bacteriophage therapy: a regulatory perspective
Eric Pelfrene et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics
Callum J. Cooper et al.
FRONTIERS IN MICROBIOLOGY (2016)
The Developing World Urgently Needs Phages to Combat Pathogenic Bacteria
Tobi E. Nagel et al.
FRONTIERS IN MICROBIOLOGY (2016)
Antibiotics: the changing regulatory and pharmaceutical industry paradigm
Richard Bax et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Available Tools to Facilitate Early Patient Access to Medicines in the EU and the USA: Analysis of Conditional Approvals and the Implications for Personalized Medicine
Lada Leyens et al.
PUBLIC HEALTH GENOMICS (2015)
Amplification and Purification of T4-Like Escherichia coli Phages for Phage Therapy: from Laboratory to Pilot Scale
Gilles Bourdin et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
Call for a Dedicated European Legal Framework for Bacteriophage Therapy
Gilbert Verbeken et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2014)
Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal products
John D. Johnston et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
MICROBIOLOGY Phage therapy gets revitalized
Sara Reardon
NATURE (2014)
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
D.D. Rhoads et al.
Journal of Wound Care (2014)
Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities
Britt Koskella et al.
FEMS MICROBIOLOGY REVIEWS (2014)
Paving a regulatory pathway for phage therapy - Europe should muster the resources to financially, technically and legally support the introduction of phage therapy
Isabelle Huys et al.
EMBO REPORTS (2013)
Optimizing the European Regulatory Framework for Sustainable Bacteriophage Therapy in Human Medicine
Gilbert Verbeken et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
Introducing yesterday's phage therapy in today's medicine
Jean-Paul Pirnay et al.
FUTURE VIROLOGY (2012)
What is needed for phage therapy to become a reality in Western medicine?
Harald Bruessow
VIROLOGY (2012)
The Phage Therapy Paradigm: Prt-A -Porter or Sur-mesure?
Jean-Paul Pirnay et al.
PHARMACEUTICAL RESEARCH (2011)
Phage Therapy Pharmacology
Stephen T. Abedon et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Bacteriophage Therapy of Salmonella enterica: A Fresh Appraisal of Bacteriophage Therapy
Rosanna Capparelli et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy
A. Wright et al.
CLINICAL OTOLARYNGOLOGY (2009)
European regulatory conundrum of phage therapy
Gilbert Verbeken et al.
FUTURE MICROBIOLOGY (2007)
Population and evolutionary dynamics of phage therapy
BR Levin et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Pharmacokinetic principles of bacteriophage therapy
RJH Payne et al.
CLINICAL PHARMACOKINETICS (2003)
Regulatory issues for phage-based clinical products
R Withington
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY (2001)
Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals
RJH Payne et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Share Paper
